Table 1 The information of the participants
From: Impact of GTF2H1 and RAD54L2 polymorphisms on the risk of lung cancer in the Chinese Han population
Characteristics | Case | Control | p |
|---|---|---|---|
Number | 506 | 510 | |
Age (mean ± SD, years) | 59.80 ± 10.63 | 59.80 ± 9.08 | 0.992 |
> 59 | 271 (53.6%) | 275 (54.3%) | |
≤ 59 | 235 (46.4%) | 235 (46.4%) | |
Gender | 0.987 | ||
Male | 350(69.2%) | 353(69.8%) | |
Female | 156(30.8%) | 157(31.2%) | |
BMI (kg/m2) | |||
≤ 24 | 133 (26.3%) | 138 (27.3%) | |
> 24 | 81 (16.0%) | 181 (35.8%) | |
Missing | 292 (57.7%) | 191 (37.7%) | |
Smoking | |||
Yes | 242 (47.8%) | 108 (27.3%) | |
No | 161 (31.8%) | 180 (35.8%) | |
Missing | 292 (20.4%) | 191 (43.5%) | |
Drinking | |||
Yes | 109 (21.5%) | 103 (20.4%) | |
No | 267 (52.8%) | 156 (30.8%) | |
Missing | 130 (25.7%) | 251 (49.6%) | |
Pathological type | |||
Lung squamous cell carcinoma | 174 (34.4%) | ||
Lung adenocarcinoma | 212 (41.9%) | ||
Missing | 120 (23.7%) | ||
Lymph node metastasis | |||
Yes | 269 (53.2%) | ||
No | 103 (20.4%) | ||
Missing | 134 (26.5%) | ||
Clinical stages | |||
I + II | 93 (18.4) | ||
III + IV | 286 (56.5) | ||
Missing | 127 (25.1%) | ||